Orchard Therapeutics
ORTX
$16.70
Share price
0.00%
Change (1 day)
244.33%
Change (1 year)
Orchard Therapeutics (ORTX) - Total assets
Total assets on the balance sheet as of September 2023 : $0.20 B
According to Orchard Therapeutics 's latest financial reports the company's total assets are $0.20 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Orchard Therapeutics - Total assets on balance sheet (from 2017 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.21 B | -32.1% |
| 2021-12-31 | $0.32 B | 14.76% |
| 2020-12-31 | $0.28 B | -29.64% |
| 2019-12-31 | $0.39 B | 9.08% |
| 2018-12-31 | $0.36 B | 276.22% |
| 2017-12-31 | $97.29 M | 2171.63% |
| 2016-12-31 | $4.28 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $8.88 M | -95.61% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.20 B | 0.00% | 🇬🇧 UK |
 Novavax NVAX | $1.79 B | 788.68% | 🇺🇸 USA |
 Novocure
NVCR | $1.14 B | 466.64% | Jersey |